A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
A2 Biotherapeutics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Kineta Inc.
Ludwig Institute for Cancer Research
Memorial Sloan Kettering Cancer Center
Duke University